RMB, the new formulation will be the future. I think this is part of why Sarissa is in no rush to sell the company. They know that the new IP will extend the life even further. So for Sarissa, waiting another 18-24 months is no big deal. Get everything buttoned up...lawsuits, FDA approval, China (if not 2026, then 2027), additional approvals in Europe (France, Germany), let Recordati gain some traction, get more traction in RoW, etc.
All of this is still going to to take another 18-24 months. So more hurry-up-and-wait.